Price $7.40 |
Market Cap
476.3M
|
Sector Health Care |
Div. Growth
-98.30%
|
|
P/E
-
|
P/B
1.07
|
P/S
0.05
|
Dividend %
0.10%
|
|
P/CF
6.7
|
P/FCF
1.6
|
Op. Cash Flow
320.4K
|
FCF
4.6
|
|
Op. Margin
0.80%
|
Net Margin
-0.70%
|
ROE
-12.80%
|
ROI
4.10%
|
|
ROA
-1.60%
|
EPS Growth
87.20%
|
Current Ratio
1.7
|
Debt/Equity
326.40%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | $11.61 | - | - | 13.29B | Strong Buy |
| Digirad Corporation (DRAD) | $2.91 | - | - | 5.8M | Strong Buy |
| Diversicare Healthcare Service (DVCR) | $1.67 | - | - | 11.3M | Strong Buy |
| Dynasil Corporation of America (DYSL) | $1.12 | - | - | 17M | Strong Buy |
| Elite Pharmaceuticals Inc (ELTP) | $0.08 | - | - | 65.8M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
